OSR Holdings, Inc.

OSRH
$0.42 (+ $0.01 + 3.62%)
Last updated: 2026-06-11 04:40 UTC
OSRH Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS68840D1028
CUSIP68840D102
Market Price0.42
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-0.26
Market Cap$14.9M
Book Value3.46
Price to Book0.168
Beta1.34
52w High12.54
52w Low0.45
Next Earnings DateN/A

OSR Holdings, Inc. trades under ticker OSRH on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US68840D1028, CUSIP 68840D102. Also searched as OSR Holdings.

Related researchOSRH stock priceOSRH share priceOSR Holdings stockOSR Holdings share price68840D102
About the Company
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.
Price History